Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation

Effects of Whole Body Vibration Training on Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients During a Three-week Rehabilitation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01380652

Enrollment

Registered

2011-06-27

Start date

2010-09-30

Completion date

2011-05-31

Last updated

2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD III/IV, Activity Monitoring, SenseWear, Vibration training, Galileo, Pulmonary rehabilitation

Brief summary

The aim of this study is to investigate the change of physical activity in COPD-patients performing a whole body vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a standard rehabilitation program.

Interventions

PROCEDUREwhole body vibration training

pulmonary rehabilitation with strength and endurance training and additionally vibration training

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Chronic obstructive pulmonary disease III/IV

Exclusion criteria

* Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics)) * Severe disease other than COPD, that could influence the results of the study * Abuse of alcohol or drugs * Simultaneously participation in another study * Tachypnea (\>30/min) * Severe exacerbation during rehabilitation * Cardiac insufficiency (NYHA IV) * Myocardial infarction during the last 6 weeks * Mental-health problem * Pregnancy * Known HIV-infection * Slipped disk * Acute discopathy * Acute thrombosis * Implants in trained regions of the body (lower extremities) * Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis * Acute tendinopathy in trained regions of the body * Acute hernia * Fresh fractures, wounds or scars in trained regions of the body * Gallstones or stones in the urinary tract collection system

Design outcomes

Primary

Measure	Time frame	Description
Activity	day 2 and 17	change in activity from baseline to day 17

Secondary

Measure	Time frame	Description
Diffusion Capacity	day 1	—
BODE-Score	day 1 and 19	Changes in Bode-Score from baseline to day 19
lung function	day 1	—

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026